Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Castlebay Investments's investment thesis on Edwards Lifesciences Corp. ($EW) — Q1 2026 | Buyside Digest

$EWNYSEEdwards Lifesciences Corp.

BULL

Castlebay Investments—EW

Fund Letter

Q1 2026

Published April 13, 2026

$90.21USD

+0.3% vs last month

$80.99Pitched

+11.4% since pitch

Market Cap$51.3B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Edwards Lifesciences is a genuinely high-quality business. Its clinical moat...

— David F. Ridland

BSD Research Exclusive

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

Other investors who've written on Edwards Lifesciences Corp.

No other institutional pitches found for this ticker yet.